Beta endorphin selectively stimulates aldosterone secretion in hypophysectomized, nephrectomized dogs.

Area of Science:

• Endocrinology
• Neuroendocrinology

Background:

• The adrenal glands secrete aldosterone and cortisol, crucial hormones regulated by the hypothalamic-pituitary-adrenal axis.
• Opioid peptides, such as beta-endorphin and enkephalins, are known to influence various physiological processes, including hormone secretion.

Purpose of the Study:

• To investigate the effects of synthetic human beta-endorphin (beta END) and a methionine-enkephalin analogue on aldosterone and cortisol secretion.
• To compare the effects of beta END with adrenocorticotropic hormone (ACTH) on adrenal steroidogenesis.

Main Methods:

• Anesthetized, hypophysectomized, and nephrectomized dogs were used, with isolated adrenal gland circulation (Hilton Pouch).
• Peptides (beta END, Met-enkephalin analogue) and ACTH were infused at 3 pmol/min into the adrenal artery.
• Aldosterone and cortisol secretion rates were calculated from adrenal blood flow and venous steroid concentrations.

Main Results:

• Beta-endorphin significantly increased aldosterone secretion rates, with effects observed at 30 and 50 minutes of infusion.
• Cortisol secretion rates were not significantly affected by beta-endorphin infusion.
• Neither the Met-enkephalin analogue nor saline infusion altered aldosterone or cortisol secretion; ACTH significantly increased both aldosterone and cortisol secretion.

Conclusions:

• Synthetic human beta-endorphin selectively stimulates aldosterone secretion in dogs.
• Beta END exhibits a potency for aldosterone stimulation comparable to an equimolar dose of ACTH.
• These findings suggest a specific role for beta END in the regulation of aldosterone secretion.